Biodesix Profit Margin

The latest profit margin for BDSX is -26.97% as of June 2026. That compares with -53.66% in the prior-year period — up 49.7% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Biodesix's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDSX's profit margin moved from -53.66% to -26.97% — a 49.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biodesix's valuation or profitability profile.

Against Healthcare companies, BDSX currently prints -26.97% for profit margin, while the sector average sits near 13.89%. That is roughly 294.2% below the sector mean. Large gaps often invite a closer look at Biodesix's growth, margins, and balance sheet.

Profit Margin shows how effectively Biodesix converts resources into returns. At -26.97%, BDSX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -53.66% in the prior-year period — up 49.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BDSX's profit margin (-26.97%), review year-over-year change from -53.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.